XML 50 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheet Components
3 Months Ended
Apr. 27, 2014
Notes to financial statements [Abstract]  
Balance Sheet Components
Balance Sheet Components
 
Certain balance sheet components are as follows:
 
April 27,
 
January 26,
 
2014
 
2014
Inventories:
(In thousands)
Raw materials
$
143,773

 
$
126,896

Work in-process
83,767

 
94,844

Finished goods
165,740

 
166,025

Total inventories
$
393,280

 
$
387,765



At April 27, 2014, we had outstanding inventory purchase obligations totaling $414.2 million.

 
April 27,
 
January 26,
 
2014
 
2014
Accrued Liabilities and Other:
(In thousands)
Deferred revenue, short-term
$
265,668

 
$
265,616

Accrued customer programs (1)
139,139

 
157,840

Accrued payroll and related expenses
86,544

 
109,721

Accrued legal settlement (2)
30,600

 
30,600

Professional service fees
12,647

 
13,572

Customer advances
10,043

 
9,297

Warranty accrual (3)
8,250

 
7,571

Office lease related liabilities
7,756

 
3,139

Coupon interest on Notes
6,250

 
2,500

Taxes payable, short-term
4,497

 
2,378

Other
17,543

 
18,871

Total accrued liabilities and other
$
588,937

 
$
621,105

      
(1)  Please refer to Note 1 of these Notes to Condensed Consolidated Financial Statements for discussion regarding the nature of accrued customer programs and their accounting treatment related to our revenue recognition policies and estimates.
(2)  Please refer to Note 12 of these Notes to Condensed Consolidated Financial Statements for discussion regarding the 3dfx litigation. 
(3)  Please refer to Note 10 of these Notes to Condensed Consolidated Financial Statements for discussion regarding the warranty accrual.
 
April 27,
 
January 26,
 
2014
 
2014
Other Long-Term Liabilities:
(In thousands)
Deferred income tax liability
$
175,236

 
$
157,953

Income taxes payable, long-term
116,881

 
119,977

Deferred revenue, long-term (1)
106,169

 
172,199

Asset retirement obligation
7,365

 
11,056

Other long-term liabilities
14,123

 
13,940

Total other long-term liabilities
$
419,774

 
$
475,125



(1) Represents annual consideration received in advance of our performance obligation under our patent cross licensing agreement with Intel Corporation entered into in January 2011. The decrease in deferred revenue, long-term, is a result of revenue recognized during the three months ended April 27, 2014.